Exploring the role of microRNAs in cancer progression and potential therapeutic applications

Thesis Abstract

Abstract
MicroRNAs (miRNAs) are small non-coding RNA molecules that play crucial roles in gene regulation and have been implicated in various biological processes, including cancer progression. This thesis explores the role of miRNAs in cancer development and their potential as therapeutic targets in cancer treatment. The study focuses on understanding the mechanisms by which miRNAs contribute to cancer progression and how they can be targeted for therapeutic interventions. The introduction provides a comprehensive overview of miRNAs, cancer biology, and the rationale for studying miRNAs in cancer. The background of the study delves into the current understanding of miRNAs and their dysregulation in cancer, highlighting their significance in cancer development and progression. The problem statement identifies the gaps in knowledge regarding specific miRNAs and their roles in different types of cancer. The objectives of the study outline the research goals and aims to address these knowledge gaps. The limitations of the study acknowledge the challenges and constraints that may affect the research outcomes. The scope of the study defines the boundaries and focus areas of the research. The significance of the study highlights the potential impact of this research on cancer treatment and patient outcomes. The structure of the thesis provides a roadmap for the organization of the research work, guiding readers through the chapters and sections. The literature review critically examines existing research on miRNAs in cancer, discussing their roles in tumor initiation, progression, metastasis, and drug resistance. The research methodology describes the experimental approaches and techniques used to investigate miRNAs in cancer, including cell culture studies, animal models, and bioinformatics analysis. The discussion of findings presents the research results, highlighting the key miRNAs involved in cancer progression and their potential as therapeutic targets. The implications of these findings for cancer treatment and future research directions are discussed in detail. In conclusion, this thesis provides insights into the role of miRNAs in cancer progression and their potential as therapeutic targets. The findings contribute to our understanding of the molecular mechanisms underlying cancer development and offer new perspectives on personalized cancer therapy. Overall, this research sheds light on the importance of miRNAs in cancer biology and opens up new avenues for targeted cancer treatment strategies.